IGF -1LR3 1MG

IGF-1 LR3 1mg is a synthetic analogue of insulin-like growth factor 1 (IGF-1), designed for research purposes. This modified peptide features an arginine substitution at the third position and an additional 13 amino acids at the N-terminus, resulting in a molecule that is approximately three times more potent than native IGF-1 and possesses a significantly longer half-life of about 20–30 hours .​

IGF-1 LR3 primarily functions by binding to the IGF-1 receptor, stimulating cell growth and division, enhancing protein synthesis, and promoting anabolism. It has been studied for its potential to improve muscle repair and hypertrophy, promote fat metabolism, and inhibit myostatin . Additionally, IGF-1 LR3 is being investigated as a potential treatment for conditions such as growth hormone deficiency, muscle wasting disorders, and insulin resistance.​

This peptide is supplied in a lyophilized (freeze-dried) form to ensure stability and is intended solely for laboratory research applications.​

Important Note: IGF-1 LR3 is intended solely for laboratory research purposes and is not approved for human or veterinary use. It should be handled by qualified professionals in a controlled environment.​